Found: 9
Select item for more details and to access through your institution.
Tumor‐Selective Activation of Toll‐Like Receptor 7/8 Agonist Nano‐Immunomodulator Generates Safe Anti‐Tumor Immune Responses upon Systemic Administration.
- Published in:
- Angewandte Chemie, 2022, v. 134, n. 52, p. 1, doi. 10.1002/ange.202214992
- By:
- Publication type:
- Article
Identification of a small-molecule Tim-3 inhibitor to potentiate T cell–mediated antitumor immunotherapy in preclinical mouse models.
- Published in:
- Science Translational Medicine, 2023, v. 15, n. 722, p. 1, doi. 10.1126/scitranslmed.adg6752
- By:
- Publication type:
- Article
In vitro ADME characterization of a very potent 3-acylamino-2-aminopropionic acid-derived GluN2C-NMDA receptor agonist and its ester prodrugs.
- Published in:
- Biological Chemistry, 2023, v. 404, n. 4, p. 255, doi. 10.1515/hsz-2022-0229
- By:
- Publication type:
- Article
Identification of Polyphenol Derivatives as Novel SARS-CoV-2 and DENV Non-Nucleoside RdRp Inhibitors.
- Published in:
- Molecules, 2023, v. 28, n. 1, p. 160, doi. 10.3390/molecules28010160
- By:
- Publication type:
- Article
Discovery and Mechanistic Investigation of Piperazinone Phenylalanine Derivatives with Terminal Indole or Benzene Ring as Novel HIV-1 Capsid Modulators.
- Published in:
- Molecules, 2022, v. 27, n. 23, p. 8415, doi. 10.3390/molecules27238415
- By:
- Publication type:
- Article
Tumor‐Selective Activation of Toll‐Like Receptor 7/8 Agonist Nano‐Immunomodulator Generates Safe Anti‐Tumor Immune Responses upon Systemic Administration.
- Published in:
- Angewandte Chemie International Edition, 2022, v. 61, n. 52, p. 1, doi. 10.1002/anie.202214992
- By:
- Publication type:
- Article
Discovery of diarylpyrimidine derivatives bearing piperazine sulfonyl as potent HIV-1 nonnucleoside reverse transcriptase inhibitors.
- Published in:
- Communications Chemistry, 2023, v. 6, n. 1, p. 1, doi. 10.1038/s42004-023-00888-4
- By:
- Publication type:
- Article
Structure‐based design of diarylpyrimidines and triarylpyrimidines as potent HIV‐1 NNRTIs with improved metabolic stability and drug resistance profiles.
- Published in:
- Journal of Medical Virology, 2024, v. 96, n. 3, p. 1, doi. 10.1002/jmv.29502
- By:
- Publication type:
- Article
Covalently Targeted Highly Conserved Tyr318 to Improve the Drug Resistance Profiles of HIV-1 NNRTIs: A Proof-of-Concept Study.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 2, p. 1215, doi. 10.3390/ijms24021215
- By:
- Publication type:
- Article